OMERS Capital Partners Invests US$30 Million In Women's HealthcareTORONTO, January 19, 2005 - OMERS Capital Partners (OCP), the private equity subsidiary of the OMERS pension plan, is now a minority equity owner in Warner Chilcott, a leading U.S. pharmaceutical company focused on women's healthcare and the dermatology market. "We are steadily building a healthcare component in our $1.5 billion private equity portfolio," commented Ian Collier, president and chief executive officer of OMERS Capital Partners. "Warner Chilcott is doing important work in oral contraception, hormone replacement therapy and dermatology. These niches are generating attractive returns we like to help pay pensions."OCP invested US$30 million in Warner Chilcott as part of the $3.1billion acquisition of the company lead by top U.S. private equity firms. The investor group included DLJ Merchant Banking, Bain Capital Partners, J.P. Morgan Partners and Thomas H. Lee Partners. Based in New Jersey, Warner Chilcott has almost 1,000 employees in the U.S., Northern Ireland and Puerto Rico. It expects to generate annual sales exceeding US$490 million. Founded in 2004, OMERS Capital Partners Inc. is a Toronto-based private equity firm employing more than 20 investment professionals. It manages a $1.5 billion diversified portfolio that is expected to expand to $4billion by 2007. OMERS Capital Partners is an OMERS Corporation with its own executive management. OMERS has been involved in private equity investing since 1989. With approximately $35.0 billion in net investment assets, OMERS is one of Canada's leading pension funds. FOR FURTHER INFORMATION PLEASE CONTACT: |
